Two of the most common SERMs are tamoxifen (Nolvadex, Soltamox) and raloxifene (Evista). There are several others as well, including lasofoxifene, bazedoxifene, and clomiphene citrate.

The selective estrogen receptor modulators tamoxifen and raloxifene have been shown to reduce the risk for breast cancer in women at high risk by as much as 50%. With an accumulation of years of ...

Selective estrogen receptor modulators (SERMS), such as tamoxifen, are widely used to prevent the recurrence of breast cancer in women who have been treated for the disease. SERMs are drugs that may ...

Tamoxifen and raloxifene slow down the progression of muscular dystrophy Long-term treatment with selective estrogen receptor modulators (SERMs) improves muscle, respiratory, and skeletal function ...

Published Aug 28, 2006 at 8:00 PM EDT Updated Mar 13, 2010 at 8:59 PM EST. By Pat Wingert . Newsweek Is A Trust Project Member ...

AACR 101st Annual Meeting WASHINGTON, D.C. — Updated results of the Study of Tamoxifen and Raloxifene P-2 indicated that at 81 months follow-up, the selective estrogen-receptor modulator ...

Tamoxifen and raloxifene slow down the progression of muscular dystrophy Long-term treatment with selective estrogen receptor modulators (SERMs) improves muscle, respiratory, and skeletal function ...

June 12 -- WEDNESDAY, June 11 (HealthDay News) -- A drug already approved to reduce the risk of breast cancer in high-risk women also seems to cut the risk for other women. A new analysis finds ...

Postmenopausal women in the studies who took drugs called selective estrogen receptor modulators (SERMs), such as tamoxifen, were 38 percent less likely to develop any type of breast cancer over a ...

SERMs and SERDS are some of the latest weapons in the fight against breast cancer. Find out how they can treat ... Raloxifene (Evista) isn't a breast cancer treatment.

Scientists in the U.S. have demonstrated that long-term therapy with the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene helps to slow disease progression in a mouse model ...

The more serious side but less common effects of SERMs include an increased of endometrial cancer, or cancer of the uterine lining. Among women in the studies, endometrial cancer was indeed more ...